Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive
First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals
Zhengxin Cai, Lindsey Drake, Mika Naganawa, Soheila Najafzadeh, Richard Pracitto, Marcel Lindemann, Songye Li, Jim Ropchan, David Labaree, Paul Emery, Mark Dias, Shannan Henry, Nabeel Nabulsi, David Matuskey, Ansel Hillmer, Richard Carson and Yiyun Huang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 462;
Zhengxin Cai
1Yale University Cheshire CT United States
Lindsey Drake
2Yale University New Haven CT United States
Mika Naganawa
2Yale University New Haven CT United States
Soheila Najafzadeh
3Yale University School of Medicine New Haven CT United States
Richard Pracitto
4Yale University PET Center New Haven CT United States
Marcel Lindemann
2Yale University New Haven CT United States
Songye Li
5PET Center Yale University New Haven CT United States
Jim Ropchan
6Yale University/PET Center Hamden CT United States
David Labaree
4Yale University PET Center New Haven CT United States
Paul Emery
7QC Yale PET Center Cheshire CT United States
Mark Dias
4Yale University PET Center New Haven CT United States
Shannan Henry
2Yale University New Haven CT United States
Nabeel Nabulsi
8Yale PET Center New Haven CT United States
David Matuskey
2Yale University New Haven CT United States
Ansel Hillmer
2Yale University New Haven CT United States
Richard Carson
2Yale University New Haven CT United States
Yiyun Huang
2Yale University New Haven CT United States
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals
Zhengxin Cai, Lindsey Drake, Mika Naganawa, Soheila Najafzadeh, Richard Pracitto, Marcel Lindemann, Songye Li, Jim Ropchan, David Labaree, Paul Emery, Mark Dias, Shannan Henry, Nabeel Nabulsi, David Matuskey, Ansel Hillmer, Richard Carson, Yiyun Huang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 462;
First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals
Zhengxin Cai, Lindsey Drake, Mika Naganawa, Soheila Najafzadeh, Richard Pracitto, Marcel Lindemann, Songye Li, Jim Ropchan, David Labaree, Paul Emery, Mark Dias, Shannan Henry, Nabeel Nabulsi, David Matuskey, Ansel Hillmer, Richard Carson, Yiyun Huang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 462;
Jump to section
Related Articles
- No related articles found.